Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$406.16M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$410.19M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$410.38M
Net Profit Margin
-13.96%
TTM Avg
-29.79%
3Y Avg
-27.76%
5Y Avg
-25.86%
Market Cap
$405.74M
Net Profit Margin
-57.42%
TTM Avg
-73.98%
3Y Avg
-95.04%
5Y Avg
-95.04%
Market Cap
$412.30M
Net Profit Margin
15.71%
TTM Avg
4.99%
3Y Avg
-8.39%
5Y Avg
-22.57%
Market Cap
$404.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.00%
Market Cap
$414.44M
Net Profit Margin
-225.34%
TTM Avg
-272.94%
3Y Avg
12.89%
5Y Avg
-949.96%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $408.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $406.16M | -58.33% | -67.34% | -66.78% | -66.78% |
| Rezolute, Inc. (RZLT)vs › | $408.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Myriad Genetics, Inc. (MYGN)vs › | $410.38M | -13.96% | -29.79% | -27.76% | -25.86% |
| Carlsmed, Inc. (CARL)vs › | $405.74M | -57.42% | -73.98% | -95.04% | -95.04% |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.30M | 15.71% | 4.99% | -8.39% | -22.57% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.04M | 0.00% | 0.00% | 0.00% | 2.00% |
| Senseonics Holdings, Inc. (SENS)vs › | $414.44M | -225.34% | -272.94% | 12.89% | -949.96% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $418.85M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -1999.14% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 11.67% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
